Latest filing published 26 Feb 2025 for Q32 Bio Inc..
Jason Campagna has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Intercept Pharmaceuticals, Inc. and Q32 Bio Inc. We count 18 filings; the first trade dates from 15 December 2019 and the latest from 24 February 2025.
Every open-market trade on record is a sale: 3 sales worth €138k. Besides market trades, the filings include 15 share grants.
Most recently, on 26 February 2025, the filings show a share grant in Q32 Bio Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations